CYE 2017 Performance Measure Crosswalk

Measures	
Acute	ALTCS E/PD	
GMS/SA	
SMI	
CMDP	
CRS	
DDD	
HEDIS	CMS Adult Core Measures	CHIPRA
Core Measures	
ADULT MEASURES			

Inpatient Utilization	
X	
X		
X	
X	
X	
X	
X			

ED Utilization	
X	
X		
X	
X	
X	
X	
X			

Hospital Readmission	
X	
X		
X			
X		
X		

Follow-Up After Hospitalization for Mental Health, 7 Days		
X	
X	
X					
X		

Follow-Up After Hospitalization for Mental Health, 30 Days		
X	
X	
X					
X		

Adults' Access to Preventive/Ambulatory Health Services	
X	
X		
X			
X	
X			

Breast Cancer Screening	
X			
X			
X		
X		

Cervical Cancer Screening	
X			
X			
X		
X		

Chlamydia Screening in Women	
X			
X			
X		
X		

Colorectal Screening	
X			
X				
X			

CDC - HbA1c Testing	
X	
X		
X			
X		
X		

CDC - HbA1c Poor Control (>9.0%)	
X	
X		
X			
X		
X		

CDC - Eye Exam	
X	
X		
X			
X	
X			

Flu Shots for Adults, Ages 18 and Older* (FVA)	
X	
X		
X			
X		
X		

Diabetes Admissions, Short-Term Complications (PQI-01)	
X	
X		
X			
X		
X		
Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate (PQI-05)	
X	
X		
X			
X		
X		

Asthma in Younger Adults Admissions (PQI-15)	
X			
X			
X		
X		

Heart Failure Admission Rate (PQI-08)	
X	
X		
X			
X		
X		

Timeliness of Prenatal Care: Prenatal Care Visit in the First Trimester or Within 42 days of Enrollment	
X			
X						
X	

Timeliness of Prenatal Care: Postpartum Care Rate	
X			
X					
X		

Mental Health Utilization	
X	
X	
X	
X		
X		
X			
Use of Opioids From Multiple Providers at High Dosage in Persons Without Cancer	
X	
X	
X	
X	
X	
X	
X		
X		

Screening for Clinical Depression and Follow-Up Plan		
X							
X		

Annual Monitoring for Patients on Persistent Medications:  Combo Rate		
X		
X			
X		
X		

Advance Directives		
X									

Access to Behavioral Health Professional Services, 7 Days			
X	
X		
X					

Access to Behavioral Health Professional Services, 23 Days			
X	specific to DDD and aggregate reporting	

X		

X					

Access to Behavioral Health Professional Services, 21 Days			X
specific to CMDP
reporting		
X						
Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medication				
X					
X		

CHILDRENS MEASURES	

Children's Access to PCPs, by age:
12-24 mo.	
X				
X	
X	
X			
X	

Children's Access to PCPs, by age:
25 mo.- 6 yrs.	
X				
X	
X	
X			
X	

Children's Access to PCPs, by age:
7 - 11 yrs.	
X				
X	
X	
X			
X	

Children's Access to PCPs, by age:
12 - 19 yrs.	
X				
X	
X	
X			
X	

Well-Child Visits: 15 mo.	
X					
X				
X	

Well-Child Visits: 3 - 6 yrs.	
X				
X	
X	
X			
X	

Adolescent Well-Child Visits: 12–21 yrs.	
X				
X	
X	
X			
X	

Children's  Dental Visits (ages 2-21)	
X				X
(2-18 yrs)	
X	
X			
X	
Weight Assessment and counseling - Body Mass Index (BMI) Assessment for Children/Adolescents	
X	
X			
X	
X	
X			
X	

EPSDT Participation	
X	X
(18-21 yrs)		X
(18-21 yrs)	
X	
X	
X				

Percentage of Eligibiles Who Received Preventive Dental Services	
X	
X			
X	
X	
X				

SEAL: Dental Sealants for Children Ages 6-9 at Elevated Caries Risk	
X	
X			
X	
X	
X			
X	

Developmental Screening in the First Three Years of Life	
X	
X			
X	
X	
X			
X	

Human Papillomavirus Vaccine for Female Adolescents	
X				
X	
X	
X			
X	
Use of Multiple Concurrent Antipsychotics in Children and Adolescents			
X		
X					
X	
Childhood Immunization Status	
DTaP	X				X	X	X			X	
IPV	X				X	X	X			X	
MMR	X				X	X	X			X	
Hib	X				X	X	X			X	

HBV	X				X	X	X			X	
VZV	X				X	X	X			X	
PCV	X				X	X	X			X	
Hep A	X				X	X	X			X	
Rotavirus	X				X	X	X			X	
Influenza	X				X	X	X			X	
Combination 3 (4:3:1:3:3:1:4)	X				X	X	X			X	
Immunizations for Adolescents	
Adolescent Meningococcal	X				X	X	X			X	
Adolescent Tdap/Td	X				X	X	X			X	
Combination 1	X				X	X	X			X	
* This measure will be Core-like